Loading…

Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy

Vascular endothelial growth factor (VEGF) signaling is an important pathway in the development of diabetic retinopathy (DR). A recent report showed that leukocyte cell-derived chemotaxin 2 (LECT2) suppresses the VEGF signaling in endothelial cells. However, the clinical relevance of LECT2 in DR is u...

Full description

Saved in:
Bibliographic Details
Published in:Clinica chimica acta 2016-12, Vol.463, p.145-149
Main Authors: Okumura, Akinori, Unoki-Kubota, Hiroyuki, Yoshida-Hata, Natsuyo, Yamamoto-Honda, Ritsuko, Yamashita, Shigeo, Iwata, Minoru, Tobe, Kazuyuki, Kajio, Hiroshi, Noda, Mitsuhiko, Katai, Naomichi, Yamagoe, Satoshi, Kaburagi, Yasushi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Vascular endothelial growth factor (VEGF) signaling is an important pathway in the development of diabetic retinopathy (DR). A recent report showed that leukocyte cell-derived chemotaxin 2 (LECT2) suppresses the VEGF signaling in endothelial cells. However, the clinical relevance of LECT2 in DR is unknown. This study aimed to investigate serum LECT2 levels and the presence of DR. The study included 230 people with type 2 diabetes mellitus (DM), 95 with DR and 135 without DR. Serum LECT2 levels were measured using an enzyme-linked immunosorbent assay. Data were evaluated using Spearman's rank correlation, univariate and multivariate logistic regression. Serum LECT2 levels were significantly lower in participants with DM having DR than in those not having DR (35.6±14.9ng/ml vs. 44.5±17.6ng/ml, P
ISSN:0009-8981
1873-3492
DOI:10.1016/j.cca.2016.10.031